ArticleJSES reviews, reports, and techniques2026
Outcomes following arthroscopic rotator cuff repair adversely affected by underlying diagnosis of glenohumeral osteoarthritis: a matched cohort analysis.
Article in JSES reviews, reports, and techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Arthroscopic rotator cuff repair (ARCR) has evolved to be the gold standard treatment for rotator cuff tears that are symptomatic despite conservative measures. Patients considered for this procedure may have underlying glenohumeral osteoarthritis (GHOA). The potential correlation of GHOA on short-term and long-term outcomes following ARCR remain unclear due to mixed literature that is limited by cohort size and/or generalizability. Methods: Patients undergoing ARCR were identified from 2010 to Q1 2022 in the M165Ortho PearlDiver Mariner Patient Claims Database. Exclusion criteria included age <18 years, prior ARCR, concurrent nonrotator cuff related arthroscopic shoulder procedures, any upper extremity fractures, neoplasms or infections diagnosed within 90 days before surgery, and <90 days follow-up in the database. Ipsilateral GHOA diagnosis within 1 year prior to ARCR was determined. ARCR (+)GHOA patients were matched 1:4 with ARCR (-)GHOA patients based on age, sex, and Elixhauser Comorbidity Index. Occurrence of any, severe, and minor adverse events within 90 days, delayed functional outcomes between 3 months and 6 months (stiffness, pain, and instability), and 2-year retear were compared by multivariable logistic regression. Two-year retear rates and 5-year subsequent total shoulder arthroplasty (TSA) were assessed by Kaplan-Meier survival analysis and compared by log-rank test. Results: Of 474,285 ARCR patients, concurrent GHOA was identified in 128,606 (27.1%). After matching, there were 84,209 ARCR (+)GHOA and 335,947 ARCR (-)GHOA patients. Compared to ARCR (-)GHOA patients, ARCR (+)GHOA patients had significantly higher odds of 90-day any adverse event (odds ratio [OR]: 1.75, Conclusion: The presence of concurrent GHOA was associated with a significant increase in the odds of both short- and longer-term complications following ARCR. These findings highlight the importance of considering GHOA in establishing treatment plans for those considered for ARCR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.